Notice of Proposed Sale · 144
Omnicell, Inc.
OMCLNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Omnicell, Inc
- Issuer CIK
- 0000926326
- SEC file number
- 000-33043
- Phone
- 8774159990
- Person for whose account securities are to be sold
- Randall Lipps
- Relationships to issuer
- Officer
- Street
- 4220 North Freeway
- City
- Fort Worth
- State / country code
- TX
- Postal code
- 76137
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 10,000 | 470,000 | 45,478,909 | 07/15/2026 | Nasdaq | Merrill Lynch |
Broker / market maker — proposed row 1, entry 1
- Name
- Merrill Lynch
- Street
- 607 West 3rd St
- Street (continued)
- Suite 2600
- City
- Austin
- State / country code
- TX
- Postal code
- 78701
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 01/16/2021 | Equity Compensation | Omnicell, Inc | 10,000 | N | 01/16/2021 | NA |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 07/15/2026
- Signed
- Randall Lipps
- Plan adoption dates
- 02/25/2026
Company context
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.